Icon

Alpine Immune Sciences Inc Stock Analysis and Price Target COMMON STOCK | Asset Management | NSD

stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 15.47

+0.40 (+2.65)%

USD 0.06B

1.21M

USD 20.78(+34.31%)

USD 8.00 (-48.29%)

Icon

ALPN

Alpine Immune Sciences Inc (USD)
COMMON STOCK | NSD
USD 15.47
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.06B

USD 8.00 (-48.29%)

USD 15.47

Alpine Immune Sciences Inc Stock Forecast

Show ratings and price targets of :
USD 20.78
(+34.31%)

Based on the Alpine Immune Sciences Inc stock forecast from 6 analysts, the average analyst target price for Alpine Immune Sciences Inc is USD 20.78 over the next 12 months. Alpine Immune Sciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Alpine Immune Sciences Inc is Slightly Bearish, which is based on 4 positive signals and 5 negative signals. At the last closing, Alpine Immune Sciences Inc’s stock price was USD 15.47. Alpine Immune Sciences Inc’s stock price has changed by +12.35% over the past week, +66.34% over the past month and +150.32% over the last year.

No recent analyst target price found for Alpine Immune Sciences Inc
No recent average analyst rating found for Alpine Immune Sciences Inc

Company Overview Alpine Immune Sciences Inc

Alpine Select AG is a publicly owned hedge fund manager. It provides its services to institutional and individual investors. It invests in the public equity markets across the globe. It invests in diversified alternative investment portfolios. The firm employs discount-, risk- ar...Read More

188 East Blaine Street, Seattle, WA, United States, 98102

3

December

CHF

Switzerland

Adjusted Closing Price for Alpine Immune Sciences Inc (ALPN)

Loading...

Unadjusted Closing Price for Alpine Immune Sciences Inc (ALPN)

Loading...

Share Trading Volume for Alpine Immune Sciences Inc Shares

Loading...

Compare Performance of Alpine Immune Sciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ALPN

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Alpine Immune Sciences Inc (Sector: Asset Management )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
TROW
T. Rowe Price Group Inc +0.77 (+0.78%) USD21.71B 13.84 7.72

ETFs Containing ALPN

Symbol Name ALPN's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Alpine Immune Sciences Inc (ALPN) Stock

Based on ratings from 6 analysts Alpine Immune Sciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 9 buy, sell and hold ratings.

ALPN stock's dividend yield is 13.99%. Our analysis grades ALPN stock's dividend yield at B-. This means that ALPN stock's dividend yield is above 82% of the stocks in the Asset Management sector in the NSD exchange. Based on this ALPN may be a good dividend stock for its sector.

Based on targets from 6 analysts, the average taret price for ALPN is USD 20.78 over the next 12 months. The maximum analyst target price is USD 30 while the minimum anlayst target price is USD 14.

Unfortunately we do not have enough data on ALPN's stock to indicate if its overvalued.

The last closing price of ALPN's stock was USD 15.47.

The most recent market capitalization for ALPN is USD 0.06B.

Based on targets from 6 analysts, the average taret price for ALPN is projected at USD 20.78 over the next 12 months. This means that ALPN's stock price may go up by +34.31% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...